News for hackers. Stuff that matters.
Re:When the Patient Is a Gold Mine: The Trouble with Rare-Di... by barrkel on Thursday May 25, 2017 @05:44AM (#14416250)
When the product is really important, we should change how we reward development, because if it's expensive, and we grant a monopoly, then the benefits of the product will be concentrated with the wealthy, rather than the many. And yes, that's not a good thing.

Consider prizes instead of patents: https://en.wikipedia.org/wiki/Prizes_as_an_alternative_to_pa...

We don't need to have a government enforced monopoly to support high prices to fund drug development. There are other ways that don't turn it into an economic ghetto either.

There are no comments on this comment yet.